Robert Lorne Hopfner is Director at Vaxcyte, Inc. (PCVX). They have made 17 open-market trades across 4 companies since 2020, most recently 2025-12-19.
CIK 0001551966
9 open-market purchases totalling $31.0M since 2020, against 8 sales. Across 9 scored buys the stock is up 5.0% at ninety days, and 2.8 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PCVX | 1,704,320 | $108.4M |
| RLYB | 1,694,388 | $27.9M |
| INZY | 2,923,110 | $11.7M |
| EVMN | 4,026 | $21K |
| Total | $148.0M |
Shares reported on the most recent Form 4, priced at the 2025-12-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 44% | 67% |
| Avg Move | -2.1% | +0.5% | +5.0% |
| Alpha | -1.5% | -0.8% | +2.8% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVMN | BUY | 2025-12-19 | 2025-12-22 | $17.35 | $17K | -10.7% | +9.5% | +36.4% |
| INZY | BUY | 2023-08-01 | 2023-08-03 | $4.80 | $4.6M | -4.4% | -4.4% | -42.7% |
| INZY | BUY | 2023-05-11 | 2023-05-15 | $6.36 | $5.7M | -14.0% | -18.1% | -29.1% |
| INZY | BUY | 2023-03-29 | 2023-03-30 | $4.54 | $3.1M | +11.0% | +18.6% | +15.9% |
| INZY | BUY | 2023-03-27 | 2023-03-29 | $4.05 | $1.7M | +17.8% | +10.2% | +9.6% |
| INZY | BUY | 2022-04-19 | 2022-04-20 | $3.69 | $3.9M | -11.6% | -12.4% | +13.1% |
| RLYB | BUY | 2021-08-02 | 2021-08-04 | $13.00 | $7.5M | -22.6% | -29.8% | -5.4% |
| PCVX | SELL | 2021-02-08 | 2021-02-10 | $27.15 | $18.0M | -10.4% | -2.0% | -35.6% |
| PCVX | SELL | 2021-02-02 | 2021-02-04 | $25.12 | $854K | +6.9% | -0.7% | -27.7% |
| PCVX | SELL | 2021-01-28 | 2021-02-02 | $25.07 | $50K | +5.5% | -4.8% | -25.4% |
| PCVX | SELL | 2021-01-25 | 2021-01-27 | $25.62 | $2.7M | +5.3% | -4.8% | -20.2% |
| PCVX | SELL | 2021-01-20 | 2021-01-22 | $25.28 | $1.5M | -4.4% | +3.1% | -23.3% |
| PCVX | SELL | 2021-01-14 | 2021-01-19 | $25.70 | $4.5M | -4.7% | -2.1% | -31.7% |
| PCVX | SELL | 2021-01-11 | 2021-01-13 | $26.34 | $4.3M | -4.1% | +1.5% | -25.4% |
| PCVX | SELL | 2021-01-06 | 2021-01-08 | $28.34 | $7.5M | -8.8% | +0.4% | -20.0% |
| INZY | BUY | 2020-07-28 | 2020-07-28 | $16.00 | $3.0M | +21.8% | +54.8% | +28.3% |
| PCVX | BUY | 2020-06-16 | 2020-06-16 | $16.00 | $1.5M | -5.9% | -23.9% | +18.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.